Archives

Project Title: “Multimodal, plasma-based biomarkers for ovarian cancer detection”

Dr. He is a chemical biologist and the John T. Wilson Distinguished Service Professor at the University of Chicago. Dr. Lengyel is an Arthur L. and Lee G. Herbst Professor of Obstetrics and Gynecology and Chair of the Department of Obstetrics and Gynecology at University of Chicago. Dr. Weigert is a Staff Scientist in the Department of Obstetrics and Gynecology at the University of Chicago.

Read more

Project Title: “Early detection of ovarian cancer using cell-free DNA fragmentomes”

Dr. Konecny is a Professor of Oncology and Obstetrics and Gynecology, and the Director of Medical Gynecologic Oncology at UCLA. Dr. Phallen is an Assistant Professor of Oncology at Johns Hopkins University School of Medicine.

Read more

Project Title: “Investigating Physico-Chemical Properties of Mesenchymal Stromal Cells as Biophysical Markers for Early Detection of Ovarian Cancers”

Dr. Belcher is the James Mason Crafts Professor of Biological Engineering, Materials Science and the Koch Institute for Integrative Cancer Research at MIT and the head of the Department of Biological Engineering at MIT. Dr. Coffman is an Assistant Professor at the University of Pittsburgh with dual appointments in the Department of Medicine, Division of Hematology/Oncology and Division of Gynecologic Oncology. Dr. Varanasi is a Professor in the Department of Mechanical Engineering at MIT.

Read more

Project Title: “Liquid Biopsy Platform to Facilitate Triage of Adnexal Mass Malignancy”

Dr. Heller is head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering Cancer Center. Dr. Long Roche is a gynecologic oncologist at the Memorial Sloan Kettering Cancer Center. Dr. Long Roche and Dr. Heller are Co-Principal Investigators on this project.

Read more

Project Title: “PapDREAM – A microfluidic platform for early, epigenetic-based detection of ovarian cancer in tissue proximal fluids”

Dr. Shih is a Richard W. TeLinde Distinguished Professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine and a board-certified attending pathologist in the Division of Gynecologic Pathology at the Johns Hopkins Hospital. Dr. Pisanic is a Senior Research Scientist at The Johns Hopkins Institute for NanoBioTechnology. Dr. Tza-Huei “Jeff” Wang is a professor in the Departments of Mechanical Engineering and Biomedical Engineering at the Johns Hopkins University and a Core Researcher at the Johns Hopkins Institute for NanoBioTechnology. Dr. Tian-Li Wang is a Professor of Pathology and Oncology, is the co-director of the Johns Hopkins Gynecologic Tissue Bank, and has extensive experience in biomarker discovery.

Read more

Project Title: “Harnessing Epigenetic Alterations in the Fallopian Tube to Develop Early Interception Strategies in Ovarian Cancer”

Dr. Buhrlage is an Associate Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and a principal investigator in the Department of Cancer Biology at Dana-Farber Cancer Institute. Dr. Drapkin is Associate Professor of Pathology in the Department of Obstetrics & Gynecology at the University of Pennsylvania and serves as Director of the Penn Ovarian Cancer Research Center (OCRC), the Director of Gynecologic Cancer Research at the Basser Center for BRCA, and Director of the Ovarian Cancer Translational Center of Excellence at the Abramson Cancer Center. Dr. Marto is an Associate Professor of Pathology at Harvard Medical School and also a principal investigator in the Department of Cancer Biology at Dana-Farber Cancer Institute. In addition, he is the Director of the Blais Proteomics Center and co-Director along with Dr. Buhrlage of the new Center for Emergent Drug Targets at Dana-Farber Cancer Institute.

Read more